Influence of Chronic Fatigue Syndrome Codiagnosis on the Relationship between Perceived and Objective Psychoneuro-Immunoendocrine Disorders in Women with Fibromyalgia

Although the predominant symptom in fibromyalgia (FM) is muscle pain, and fatigue in chronic fatigue syndrome (CFS), differential diagnosis is very difficult. This research investigates the psychoneuroimmunoendocrine disorders of FM patients and ascertains whether a previous CFS diagnosis affected them. Through accelerometry objective parameters, physical activity/sedentarism levels in relation to fatigue are studied, as well as whether perceived levels of stress, anxiety, and pain correspond to objective biomarkers, all of these with respect to a reference group (RG) of women without FM. FM patients have a worse psychological state and perceived quality of life than those with RG. These perceived outcomes are consistent with impaired objective levels of a sedentary lifestyle, higher systemic levels of cortisol and noradrenaline, and lower levels of serotonin. However, FM patients with a previous CFS diagnosis had lower systemic levels of IL-8, cortisol, oxytocin, and higher levels of adrenaline and serotonin than FM patients without diagnosed CFS. In conclusion, while perceived health parameters do not detect differences, when objective neuroimmunoendocrine parameters related to stress, inflammation, pain, and fatigue are used, people with CFS could be overdiagnosed with FM. This reinforces the need for objective biomarker assessment of these patients for better diagnostic discrimination between both syndromes.

[1]  M. D. Hinchado,et al.  Synbiotic Supplementation Improves Quality of Life and Inmunoneuroendocrine Response in Patients with Fibromyalgia: Influence of Codiagnosis with Chronic Fatigue Syndrome , 2023, Nutrients.

[2]  L. Martín-Cordero,et al.  Influence of Codiagnosis of Chronic Fatigue Syndrome and Habitual Physical Exercise on the Psychological Status and Quality of Life of Patients with Fibromyalgia , 2022, Journal of clinical medicine.

[3]  T. Caycho-Rodríguez,et al.  Measurement of coronaphobia in older adults: Validation of the Spanish version of the Coronavirus Anxiety Scale , 2021, Revista Española de Geriatría y Gerontología.

[4]  Lindsay P Toth,et al.  Time Trends in Physical Activity Using Wearable Devices: A Systematic Review and Meta-analysis of Studies from 1995 to 2017 , 2021, Medicine and science in sports and exercise.

[5]  M. Robles-Bello,et al.  The COVID-19 Fear Scale (FCV-19S): Psychometric properties and invariance of the measure in the Spanish version. , 2021, Actas espanolas de psiquiatria.

[6]  R. Smeets,et al.  An exploratory study of discrepancies between objective and subjective measurement of the physical activity level in female patients with chronic fatigue syndrome. , 2021, Journal of psychosomatic research.

[7]  Sherman A. Lee Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety , 2020, Death studies.

[8]  M. Neumeister,et al.  Fibromyalgia. , 2020, Clinics in plastic surgery.

[9]  A. Pakpour,et al.  The Fear of COVID-19 Scale: Development and Initial Validation , 2020, International Journal of Mental Health and Addiction.

[10]  M. Koutsilieris,et al.  The effect of treatment regimens on salivary cortisol levels in patients with chronic musculoskeletal disorders. , 2020, Journal of bodywork and movement therapies.

[11]  B. Lidbury,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review , 2019, Diagnostics.

[12]  Serge Marchand,et al.  Impact of a specific training programme on the neuromodulation of pain in female patient with fibromyalgia (DouFiSport): a 24-month, controlled, randomised, double-blind protocol , 2019, BMJ Open.

[13]  F. Molina,et al.  Catecholamine and Indolamine Pathway: A Case–Control Study in Fibromyalgia , 2018, Biological research for nursing.

[14]  U. Nater,et al.  Hair and salivary cortisol in a cohort of women with chronic fatigue syndrome , 2018, Hormones and Behavior.

[15]  N. Üçeyler,et al.  Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia , 2018, The Cochrane database of systematic reviews.

[16]  G. Buela-Casal,et al.  Short form of the Spanish adaptation of the State-Trait Anxiety Inventory , 2017, International journal of clinical and health psychology : IJCHP.

[17]  A. Marques,et al.  Prevalence of fibromyalgia: literature review update. , 2017, Revista brasileira de reumatologia.

[18]  R. Geenen,et al.  The discordance between subjectively and objectively measured physical function in women with fibromyalgia: association with catastrophizing and self-efficacy cognitions. The al-Ándalus project , 2016, Disability and rehabilitation.

[19]  Philip J Mease,et al.  2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2016, Seminars in arthritis and rheumatism.

[20]  E. Ortega The “bioregulatory effect of exercise” on the innate/inflammatory responses , 2016, Journal of Physiology and Biochemistry.

[21]  M. Fletcher,et al.  Illness progression in chronic fatigue syndrome: a shifting immune baseline , 2016, BMC Immunology.

[22]  N. Pattyn,et al.  Associations Between Cognitive Performance and Pain in Chronic Fatigue Syndrome: Comorbidity with Fibromyalgia Does Matter. , 2015, Pain physician.

[23]  C. Vázquez,et al.  Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): 2. Propiedades psicométricas en población general The spanish adaptation of Beck's Depression Inventory-II (BDI-II): 2. Psychometric properties in the general population , 2015 .

[24]  S. Mackey,et al.  Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status , 2014, Journal of pain research.

[25]  E. Ortega,et al.  Soluble fractalkine in the plasma of fibromyalgia patients. , 2014, Anais da Academia Brasileira de Ciencias.

[26]  G. Chrousos,et al.  The Healthy Lifestyle and Personal Control Questionnaire (HLPCQ): a novel tool for assessing self-empowerment through a constellation of daily activities , 2014, BMC Public Health.

[27]  J. García,et al.  Altered profile of chemokines in fibromyalgia patients , 2014, Annals of clinical biochemistry.

[28]  M. D. Hinchado,et al.  An exploratory study of the effect of regular aquatic exercise on the function of neutrophils from women with fibromyalgia: Role of IL-8 and noradrenaline , 2014, Brain, Behavior, and Immunity.

[29]  R. Moss‐Morris,et al.  Unstimulated cortisol secretory activity in everyday life and its relationship with fatigue and chronic fatigue syndrome: A systematic review and subset meta-analysis , 2013, Psychoneuroendocrinology.

[30]  M. D. Hinchado,et al.  Fibromyalgia: Anti-Inflammatory and Stress Responses after Acute Moderate Exercise , 2013, PloS one.

[31]  P. Wiffen SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS (SNRIs) FOR FIBROMYALGIA SYNDROME , 2013 .

[32]  G. Cardon,et al.  Actigraph GT3X: Validation and Determination of Physical Activity Intensity Cut Points , 2013, International Journal of Sports Medicine.

[33]  Gordon Broderick,et al.  Biomarkers for chronic fatigue , 2012, Brain, Behavior, and Immunity.

[34]  J. García,et al.  Inflammatory/Stress Feedback Dysregulation in Women with Fibromyalgia , 2012, Neuroimmunomodulation.

[35]  Charles D. Spielberger,et al.  State-Trait Anxiety Inventory for Adults , 2012 .

[36]  E. Giraldo,et al.  Aquatic exercise improves the monocyte pro‐ and anti‐inflammatory cytokine production balance in fibromyalgia patients , 2012, Scandinavian journal of medicine & science in sports.

[37]  M. Yunus The Prevalence of Fibromyalgia in Other Chronic Pain Conditions , 2011, Pain research and treatment.

[38]  D. Cook,et al.  Are women with fibromyalgia less physically active than healthy women? , 2011, Medicine and science in sports and exercise.

[39]  P. Kellam,et al.  Assessment of a 44 Gene Classifier for the Evaluation of Chronic Fatigue Syndrome from Peripheral Blood Mononuclear Cell Gene Expression , 2011, PloS one.

[40]  L. D. Robredo,et al.  Estabilidad emocional y cortisol como factores diferenciadores de la fibromialgia , 2011 .

[41]  K. Mannerkorpi,et al.  Transcultural adaptation and psychometric properties of a Spanish-language version of physical activity instruments for patients with fibromyalgia. , 2011, Archives of physical medicine and rehabilitation.

[42]  F. Salaffi,et al.  Pharmacological treatment of fibromyalgia. , 2010, Clinical and experimental rheumatology.

[43]  S. Wessely,et al.  Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome? , 2009, Psychological Medicine.

[44]  D. Buskila,et al.  Pathogenesis of fibromyalgia - a review. , 2008, Joint, bone, spine : revue du rhumatisme.

[45]  Paul Kellam,et al.  Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. , 2008, The Journal of infectious diseases.

[46]  H. Besedovsky,et al.  Physiology of psychoneuroimmunology: A personal view , 2007, Brain, Behavior, and Immunity.

[47]  E. Remor,et al.  Psychometric Properties of a European Spanish Version of the Perceived Stress Scale (PSS) , 2006, The Spanish Journal of Psychology.

[48]  J. Rivera,et al.  The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. , 2004, Clinical and experimental rheumatology.

[49]  K. Nas,et al.  Cortisol and hypothalamic–pituitary–gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones , 2004, Arthritis research & therapy.

[50]  D. Buchwald,et al.  Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. , 2003, Best practice & research. Clinical rheumatology.

[51]  R. Shephard Limits to the measurement of habitual physical activity by questionnaires , 2003, British journal of sports medicine.

[52]  C. Cleeland,et al.  Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica , 2003 .

[53]  T. Pollmächer,et al.  The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. , 2002, The Journal of endocrinology.

[54]  G. Chrousos,et al.  Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.

[55]  D. Papanicolaou,et al.  Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. , 2000, Arthritis and rheumatism.

[56]  P. Keck,et al.  Antidepressant treatment of fibromyalgia. A meta-analysis and review. , 2000, Psychosomatics.

[57]  C. Cleeland,et al.  The rapid assessment of fatigue severity in cancer patients , 1999, Cancer.

[58]  M. Mikkelsson One year outcome of preadolescents with fibromyalgia. , 1999, The Journal of rheumatology.

[59]  P S Freedson,et al.  Calibration of the Computer Science and Applications, Inc. accelerometer. , 1998, Medicine and science in sports and exercise.

[60]  R. Daynes,et al.  Dysregulation of IL-10 production with aging: Possible linkage to the age-associated decline in DHEA and its sulfated derivative , 1996, Experimental Gerontology.

[61]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[62]  S. Pillemer,et al.  Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. , 1994, Arthritis and rheumatism.

[63]  D. Buchwald,et al.  Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. , 1994, Archives of internal medicine.

[64]  R M Bennett,et al.  The fibromyalgia impact questionnaire: development and validation. , 1991, The Journal of rheumatology.

[65]  A. Komaroff,et al.  High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. , 1990, Arthritis and rheumatism.

[66]  T. Kamarck,et al.  A global measure of perceived stress. , 1983, Journal of health and social behavior.

[67]  C. Cleeland,et al.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases , 1983, Pain.

[68]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[69]  A. Marques,et al.  Prevalence of fibromyalgia: literature review update. , 2017, Revista brasileira de reumatologia.

[70]  Julián Pérez-Villacastín,et al.  [Evolution and scientific impact of research grants from the spanish society of cardiology and spanish heart foundation (2000-2006)]. , 2011, Revista espanola de cardiologia.

[71]  F. Félix-Redondo,et al.  [Prevalence, awareness, treatment and control of cardiovascular risk factors in the Extremadura population (Spain). HERMEX study]. , 2011, Atencion primaria.

[72]  H. Northoff,et al.  Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances. , 2009, Exercise immunology review.

[73]  I. Russell,et al.  Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. , 1992, The Journal of rheumatology.

[74]  G. A. Mccain,et al.  Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. , 1989, The Journal of rheumatology. Supplement.